SLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q4 2023

Source: iQoncept / Shutterstock
Soleno Therapeutics (NASDAQ:SLNO) just reported results for the fourth quarter of 2023.
- Soleno Therapeutics reported earnings per share of -33 cents. This was below the analyst estimate for EPS of -27 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/slno-stock-earnings-soleno-therapeutics-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC